Home > Journals > Medicina dello Sport > Past Issues > Medicina dello Sport 2021 March;74(1) > Medicina dello Sport 2021 March;74(1):1-21

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Medicina dello Sport 2021 March;74(1):1-21

DOI: 10.23736/S0025-7826.21.03907-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English, Italian

Medical-health recommendations for the Serie A League

Maurizio CASASCO 1, 2, 3 , Sergio PECORELLI 4, 5, Alessandro CORSINI 1, Francesco DE FERRARI 5, Massimo GALLI 3, Maurizio MEMO 5, Luigi MORI 1, Giuseppe NOVELLI 6, 7, Carlo SIGNORELLI 8, 9, Andrea VERZELETTI 1, 5, Fabio PIGOZZI 1, 10, 11

1 Federazione Medico Sportiva Italiana, Rome, Italy; 2 European Federation of Sports Medicine Associations, Rome, Italy; 3 University of Milan, Milan, Italy; 4 Giovanni Lorenzini Medical Foundation, New York, NY, USA; 5 University of Brescia, Brescia, Italy; 6 Giovanni Lorenzini Medical Science Foundation, Milan, Italy; 7 Tor Vergata University, Rome, Italy; 8 University of Parma, Parma, Italy; 9 Vita-Salute San Raffaele University, Milan, Italy; 10 International Federation of Sports Medicine, Lausanne, Switzerland; 11 University of Rome "Foro Italico", Rome, Italy


PDF


Given the most recent epidemiological data and in view of the increasing spread of the Sars-CoV-2 virus in society as a whole and the world of sport in particular, the following medical and health recommendations are proposed to implement the FIGC regulations, approved by the CTS and already in place for professional soccer and the LEGA Serie A, in order to: 1) protect the health of individual players and the team group and reduce the risk of contracting the Sars-CoV-2 virus for all members and employees of Serie A Clubs by means of periodic and preventive monitoring; 2) reduce the spread of the virus from within the group to the general public, by taking social responsibility; and 3) standardize management of the testing, transport, analysis and reporting process of the system. In order to pursue these objectives and optimize the recommendations set out below, it is necessary: 1) to identify a single company/central laboratory to contact in order to guarantee a consistent method in the management of the testing, transport, analysis and reporting processes of molecular swabs (PCR). All Serie A clubs shall refer to this company/central laboratory, recognizing its exclusive status for the execution of such processes; 2) to identify a contact authority available 24h (with dedicated email and telephone) within Serie A for the coordination and management of every need and/or emergency; 3) for the Ministry of Health to activate a contact figure to coordinate and oversee each local ATS/ASL so as to guarantee that clubs receive uniform indications and provisions and to act as interface for the entire professional system. This central figure will delegate the management of everyday business to the various local ATS/ASLs, receiving constant, up-to-date feedback; and 4) to urge the Ministry of Health to adopt uniform procedures within the National Health System (local ATS/ASLs) in matters of management of players who test positive a second time after announcing their recovery and management of players who, in contact quarantine, are called up to the national team or who return from it. The FMSI may also make its DCOs available, as an opportunity to be agreed with the FIGC and the AIA, to perform rapid antigen tests on the refereeing group 2 hours before a game. The following recommendations are subject to review considering new scientific and epidemiological evidence.


KEY WORDS: Sports; Sars-CoV-2; Epidemiology

top of page